Moderna, Inc.MRNANASDAQ
LOADING
|||
EBITDA Over Time
Below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-3.39B
↓ 309% below average
Average (8y)
$1.62B
Historical baseline
Range
High:$13.53B
Low:$-3.39B
CAGR
+41.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-3.39B | -3.4% |
| 2023 | $-3.28B | -133.6% |
| 2022 | $9.77B | -27.8% |
| 2021 | $13.53B | +2023.3% |
| 2020 | $-703.38M | -47.4% |
| 2019 | $-477.08M | -15.8% |
| 2018 | $-412.05M | -75.1% |
| 2017 | $-235.33M | -12.8% |
| 2016 | $-208.66M | - |